Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Invested Capital (2018 - 2025)

Revolution Medicines (RVMD) has 7 years of Invested Capital data on record, last reported at $1.6 billion in Q4 2025.

  • For Q4 2025, Invested Capital fell 27.98% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 27.98%, while the annual FY2025 figure was $1.6 billion, 27.98% down from the prior year.
  • Invested Capital reached $1.6 billion in Q4 2025 per RVMD's latest filing, up from $1.6 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $2.3 billion in Q4 2024 and bottomed at $498.8 million in Q2 2022.
  • Average Invested Capital over 5 years is $1.2 billion, with a median of $941.5 million recorded in 2023.
  • Peak YoY movement for Invested Capital: soared 166.52% in 2023, then fell 27.98% in 2025.
  • A 5-year view of Invested Capital shows it stood at $602.6 million in 2021, then increased by 13.71% to $685.2 million in 2022, then skyrocketed by 166.52% to $1.8 billion in 2023, then rose by 24.04% to $2.3 billion in 2024, then dropped by 27.98% to $1.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.9 billion in Q2 2025.